title: Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).
authors.affiliation: Department of Dermatology, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea.
authors.forename: Yong-Sun
authors.initials: YS
authors.lastname: Cho
authors.forename: Jin
authors.initials: J
authors.lastname: Park
authors.forename: Ju-Ik
authors.initials: JI
authors.lastname: Kim
authors.forename: Kyung-Hwa
authors.initials: KH
authors.lastname: Nam
authors.forename: Seok-Kweon
authors.initials: SK
authors.lastname: Yun
authors.forename: Han-Uk
authors.initials: HU
authors.lastname: Kim
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D005260:Female; D060831:Hand-Foot Syndrome / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride